s6y
Company name or ticker
Search
Dyne Therapeutics, Inc.
144
Atlas Venture Opportunity Fund II, L.P.: Notice of proposed sale of restricted stock
Filed
Friday, August 14, 2026
Accession number
0001628280-26-057188
Documents
Notice of proposed sale of restricted stock
144
Exhibits
99
Additional exhibit
EX-99
On sec.gov
Filing index
All files
Complete submission text
SGML header